Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/Ritonavir Dosing Strategies for HIV/TB Co-infection
NCT01601626Phase 2Terminated
- Start
- Jul 2013
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 2 trial of lopinavir, ritonavir, raltegravir in human immunodeficiency virus infection (HIV). Started Jul 2013; status: terminated.
02
Drugs
lopinavirritonavirraltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01601626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601626.